市場調査レポート

世界の手術専用創傷ケア製品市場 2016年:外科用シーラント、接着剤、吸収性止血剤および癒着防止製品

2016 Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products

発行 Life Science Intelligence, Inc. 商品コード 278727
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
世界の手術専用創傷ケア製品市場 2016年:外科用シーラント、接着剤、吸収性止血剤および癒着防止製品 2016 Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products
出版日: 2016年01月29日 ページ情報: 英文
概要

シーラント、接着剤、吸収性止血剤および癒着防止製品を含めた世界の手術専用創傷ケア製品市場規模は、2014年に32億米ドルとなりました。同市場の成長に影響を及ぼす主な要因は、手術件数の増加で、世界の収益は2020年までに44億米ドルに達すると予測されています。

当レポートでは、世界の手術専用創傷ケア製品市場について調査し、地域および製品タイプ別の市場分析と予測を提供しており、サプライヤーのシェア分析などをまとめ、お届けいたします。

市場モデル

第1章

  • 世界の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:製品タイプ別
  • 世界の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:地域別
  • 米国の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:製品タイプ別
  • 欧州のの外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:製品タイプ別
  • アジア太平洋 (AP) & その他 (ROW) の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:製品タイプ別
  • 世界のサプライヤーシェア

第2章

  • 世界の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:製品タイプ別
  • 世界の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:地域別
  • 米国の外科用シーラント、接着剤、吸収性止血剤および癒着防止製品市場:製品タイプ別
  • 米国における対象手術の取扱件数
  • 米国における外部・内部組織シーラント市場予測
  • 米国における外科用接着剤市場予測
  • 米国における外科用接着剤、承認 & オフラベルユース (適応外使用) 市場の予測
  • 米国における吸収性止血剤市場予測
  • 米国における癒着防止製品市場予測
  • 米国サプライヤーのシェア
  • 欧州における対象手術の取扱件数
  • 欧州における外部・内部組織シーラント市場予測
  • 欧州における外科用接着剤市場予測
  • 欧州における外科用接着剤、承認 & オフラベルユース (適応外使用) 市場の予測
  • 欧州における吸収性止血剤市場予測
  • 欧州における癒着防止製品市場予測
  • AP & ROW における対象手術の取扱件数
  • AP & ROW における外部・内部組織シーラント市場予測
  • AP & ROW における外科用接着剤市場予測
  • AP & ROW における外科用接着剤、承認 & オフラベルユース (適応外使用) 市場の予測
  • AP & ROW における吸収性止血剤市場予測
  • AP & ROW における癒着防止製品市場予測
  • OUSサプライヤーのシェア

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: LSI-WW151WO

About the global market:

The global market for specialty surgical wound care products-which includes sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.2 billion in 2014. The main factor influencing growth in the market is surgical volumes; rising numbers of surgeries in major global markets will generate greater revenues through 2020, when total sales are projected to reach $4.4 billion. Sales of absorbable hemostats and adhesion prevention products are expected to increase at the swiftest rates, followed by surgical glues and sealants.

Factors driving growth through 2020 include the following:

  • 1. Rising surgical volumes due to greater access to healthcare in the U.S. and emerging markets. Favorable demographics in mature markets such as Japan and Western Europe should generate mild increases in annual caseloads;
  • 2. Growing utilization in emerging markets and important surgical applications, such as cardiothoracic surgery and neurosurgery; and
  • 3. New product introductions which will help to sustain pricing levels.

Factors limiting growth through 2020 include the following:

  • 1. Cost-containment efforts in key regional markets, such as Europe, which should lead to price erosion;
  • 2. Important shifts in surgical technique, such as the rising use of laparoscopy in gastrointestinal surgery; and
  • 3. The relative maturity of important segments, such as surgical glues for open surgical repairs of the aorta, carotid, and femoral arteries.

Leading suppliers to the global market include Ethicon (Johnson & Johnson); Baxter International; Genzyme (Sanofi-Aventis); Takeda Pharmaceuticals International; King Pharmaceuticals (Pfizer); The Medicines Company; Integra LifeSciences; and CryoLife. Other suppliers included CSL Behring; Davol, Neomend, and Medafor (C.R. Bard); HemCon Medical Technologies; Hyperbranch Medical Technology; MAST Biosurgery; Orthovita (Stryker); Tenaxis Medical; ThermoGenesis; Tissuemed; and Vivostat A/S.

Companies covered

The following companies are covered in this report:

  • 1. Baxter International
  • 2. CryoLife
  • 3. CSL Behring
  • 4. Davol
  • 5. Ethicon (Johnson & Johnson)
  • 6. Genzyme (Sanofi-Aventis)
  • 7. HemCon Medical Technologies
  • 8. Hyperbranch Medical Technology
  • 9. Integra LifeSciences
  • 10. King Pharmaceuticals (Pfizer)
  • 11. MAST Biosurgery
  • 12. Medafor (C.R. Bard)
  • 13. Neomend
  • 14. Orthovita (Stryker)
  • 15. Takeda Pharmaceuticals International
  • 16. Tenaxis Medical
  • 17. ThermoGenesis
  • 18. Tissuemed
  • 19. Vivostat A/S
  • 20. Zymogenetics (Bristol-Myers Squibb)

Table of Contents

Market Models

  • Market Model 1-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region
  • Market Model 1-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-4: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-5: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 1-6: Global Supplier Shares in 2013 and 2014
  • Market Model 2-1: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-2: The Global Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Region
  • Market Model 2-3: The U.S. Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-4: Targeted Surgical Caseloads in the U.S. from 2013-2020
  • Market Model 2-5: The U.S. Market Forecast for External and Internal Tissue Sealants from 2013-2020
  • Market Model 2-6: The U.S. Market Forecast for Surgical Glues from 2013-2020
  • Market Model 2-7: The U.S. Market Forecast for Surgical Glues, Approved & Off-Label Uses, from 2013-2020
  • Market Model 2-8: The U.S. Market Forecast for Absorbable Hemostats from 2013-2020
  • Market Model 2-9: The U.S. Market Forecast for Adhesion Prevention Products from 2013-2020
  • Market Model 2-10: U.S. Supplier Shares in 2013 and 2014
  • Market Model 2-11: The European Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-12: Targeted Surgical Caseloads in Europe from 2013-2020
  • Market Model 2-13: The European Market Forecast for Surgical Sealants from 2013-2020
  • Market Model 2-14: The European Market Forecast for External and Internal Tissue Sealants from 2013-2020
  • Market Model 2-15: The European Market Forecast for Surgical Glues from 2013-2020
  • Market Model 2-16: The European Market Forecast for Surgical Glues from 2013-2020: Open Repairs of the Large Vessels & Other Indications
  • Market Model 2-17: The European Market Forecast for Absorbable Hemostats from 2013-2020
  • Market Model 2-18: The European Market Forecast for Adhesion Prevention Products from 2013-2020
  • Market Model 2-19: The AP & ROW Market Forecast for Surgical Sealants, Glues, Absorbable Hemostats, & Adhesion Prevention Products by Product Type
  • Market Model 2-20: Targeted Surgical Caseloads in AP & ROW Countries from 2013-2020
  • Market Model 2-21: The AP & ROW Market Forecast for Surgical Sealants from 2013-2020
  • Market Model 2-22: The AP & ROW Market Forecast for External and Internal Tissue Sealants from 2013-2020
  • Market Model 2-23: The AP & ROW Market Forecast for Surgical Glues from 2013-2020
  • Market Model 2-24: The AP & ROW Market Forecast for Surgical Glues from 2013-2020: Open Repairs of the Large Vessels & Other Indications
  • Market Model 2-25: The AP & ROW Market Forecast for Absorbable Hemostats from 2013-2020
  • Market Model 2-26: The AP & ROW Market Forecast for Adhesion Prevention Products from 2013-2020
  • Market Model 2-27: OUS Supplier Shares in 2013 and 2014
Back to Top